Veronica Wendy Setiawan1,2, Daniel O Stram1, Jacqueline Porcel2, Suresh T Chari3, Gertraud Maskarinec4, Loïc Le Marchand4, Lynne R Wilkens4, Christopher A Haiman1,2, Stephen J Pandol5, Kristine R Monroe1. 1. Department of Preventive Medicine, Keck School of Medicine of University of Southern California, Los Angeles, CA. 2. Norris Comprehensive Cancer Center, Keck School of Medicine of University of Southern California, Los Angeles, CA. 3. Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, MN. 4. Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI. 5. Division of Gastroenterology, Departments of Medicine, Cedars-Sinai Medical Center and Department of Veterans Affairs, Los Angeles, CA.
Abstract
Background: Diabetes has been proposed to be a risk factor for and a consequence of pancreatic cancer (PC). The relationship between recent-onset diabetes and PC is not well understood, and data in minorities are sparse. We examined the relationships between recent-onset diabetes and PC incidence in African Americans and Latinos in the Multiethnic Cohort. Methods: A total of 48 995 African Americans and Latinos without prior diabetes and cancer at baseline (1993-1996) were included in the study. Questionnaires, Medicare data, and California hospital discharge files were used to identify new diabetes diagnoses. Cox regressions were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer associated with diabetes and with diabetes duration. Results: A total of 15 833 (32.3%) participants developed diabetes between baseline and 2013. A total of 408 incident PC cases were identified during follow-up. Diabetes was associated with PC (HRage75 = 2.39, 95% CI = 1.91 to 2.98). Individuals with recent-onset diabetes (within three or fewer years of PC diagnosis) had a greater risk compared with those with long-term diabetes across all ages. The HRage75 for recent-onset diabetes was 4.08 (95% CI = 2.76 to 6.03) in Latinos and 3.38 (95% CI = 2.30 to 4.98) in African Americans. Conclusions: Diabetes was associated with a more than twofold higher risk of PC in African Americans and Latinos, but recent-onset diabetes was associated with a 2.3-fold greater increase in risk of PC than long-standing diabetes. Our findings support the hypothesis that recent-onset diabetes is a manifestation of PC and that long-standing diabetes is a risk factor for this malignancy.
Background: Diabetes has been proposed to be a risk factor for and a consequence of pancreatic cancer (PC). The relationship between recent-onset diabetes and PC is not well understood, and data in minorities are sparse. We examined the relationships between recent-onset diabetes and PC incidence in African Americans and Latinos in the Multiethnic Cohort. Methods: A total of 48 995 African Americans and Latinos without prior diabetes and cancer at baseline (1993-1996) were included in the study. Questionnaires, Medicare data, and California hospital discharge files were used to identify new diabetes diagnoses. Cox regressions were used to calculate hazard ratios (HRs) and 95% confidence intervals (CIs) for cancer associated with diabetes and with diabetes duration. Results: A total of 15 833 (32.3%) participants developed diabetes between baseline and 2013. A total of 408 incident PC cases were identified during follow-up. Diabetes was associated with PC (HRage75 = 2.39, 95% CI = 1.91 to 2.98). Individuals with recent-onset diabetes (within three or fewer years of PC diagnosis) had a greater risk compared with those with long-term diabetes across all ages. The HRage75 for recent-onset diabetes was 4.08 (95% CI = 2.76 to 6.03) in Latinos and 3.38 (95% CI = 2.30 to 4.98) in African Americans. Conclusions: Diabetes was associated with a more than twofold higher risk of PC in African Americans and Latinos, but recent-onset diabetes was associated with a 2.3-fold greater increase in risk of PC than long-standing diabetes. Our findings support the hypothesis that recent-onset diabetes is a manifestation of PC and that long-standing diabetes is a risk factor for this malignancy.
Authors: Samir Gupta; Eric Vittinghoff; Daniel Bertenthal; Douglas Corley; Hui Shen; Louise C Walter; Kenneth McQuaid Journal: Clin Gastroenterol Hepatol Date: 2006-09-01 Impact factor: 11.382
Authors: Donghui Li; Hongwei Tang; Manal M Hassan; Elizabeth A Holly; Paige M Bracci; Debra T Silverman Journal: Cancer Causes Control Date: 2010-11-21 Impact factor: 2.506
Authors: L N Kolonel; B E Henderson; J H Hankin; A M Nomura; L R Wilkens; M C Pike; D O Stram; K R Monroe; M E Earle; F S Nagamine Journal: Am J Epidemiol Date: 2000-02-15 Impact factor: 4.897
Authors: Suresh T Chari; Cynthia L Leibson; Kari G Rabe; Lawrence J Timmons; Jeanine Ransom; Mariza de Andrade; Gloria M Petersen Journal: Gastroenterology Date: 2007-10-26 Impact factor: 22.682
Authors: Rahul Pannala; Jeffery B Leirness; William R Bamlet; Ananda Basu; Gloria M Petersen; Suresh T Chari Journal: Gastroenterology Date: 2008-01-18 Impact factor: 22.682
Authors: Brian Z Huang; Stephen J Pandol; Christie Y Jeon; Suresh T Chari; Catherine A Sugar; Chun R Chao; Zuo-Feng Zhang; Bechien U Wu; Veronica Wendy Setiawan Journal: Clin Gastroenterol Hepatol Date: 2019-12-04 Impact factor: 11.382
Authors: Barbara Kenner; Suresh T Chari; David Kelsen; David S Klimstra; Stephen J Pandol; Michael Rosenthal; Anil K Rustgi; James A Taylor; Adam Yala; Noura Abul-Husn; Dana K Andersen; David Bernstein; Søren Brunak; Marcia Irene Canto; Yonina C Eldar; Elliot K Fishman; Julie Fleshman; Vay Liang W Go; Jane M Holt; Bruce Field; Ann Goldberg; William Hoos; Christine Iacobuzio-Donahue; Debiao Li; Graham Lidgard; Anirban Maitra; Lynn M Matrisian; Sung Poblete; Laura Rothschild; Chris Sander; Lawrence H Schwartz; Uri Shalit; Sudhir Srivastava; Brian Wolpin Journal: Pancreas Date: 2021-03-01 Impact factor: 3.243
Authors: Christie Y Jeon; Sungjin Kim; Yu-Chen Lin; Harvey A Risch; Mark O Goodarzi; Teryl K Nuckols; Stephen J Freedland; Stephen J Pandol; Joseph R Pisegna Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-11-02 Impact factor: 4.090
Authors: Michael Goggins; Kasper Alexander Overbeek; Randall Brand; Sapna Syngal; Marco Del Chiaro; Detlef K Bartsch; Claudio Bassi; Alfredo Carrato; James Farrell; Elliot K Fishman; Paul Fockens; Thomas M Gress; Jeanin E van Hooft; R H Hruban; Fay Kastrinos; Allison Klein; Anne Marie Lennon; Aimee Lucas; Walter Park; Anil Rustgi; Diane Simeone; Elena Stoffel; Hans F A Vasen; Djuna L Cahen; Marcia Irene Canto; Marco Bruno Journal: Gut Date: 2019-10-31 Impact factor: 23.059
Authors: Bechien U Wu; Eva Lustigova; Qiaoling Chen; Elizabeth Y Dong; Anirban Maitra; Suresh T Chari; Ziding Feng; Jo Ann Rinaudo; Lynn M Matrisian; Rex A Parker Journal: Clin Transl Gastroenterol Date: 2022-06-01 Impact factor: 4.396